Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach?

We describe the effect of interleukin 6 (IL-6) blockade using tocilizumab (TCZ) for inducing and maintaining remission of refractory polyarteritis nodosa (PAN). Three patients with refractory PAN defined according to the American College of Rheumatology criteria were treated with TCZ infusions (8 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Saunier, Aurélie, Issa, Nahéma, Vandenhende, Marie-Anne, Morlat, Philippe, Doutre, Marie-Sylvie, Bonnet, Fabrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574418/
https://www.ncbi.nlm.nih.gov/pubmed/28879047
http://dx.doi.org/10.1136/rmdopen-2017-000446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574418/
https://www.ncbi.nlm.nih.gov/pubmed/28879047
http://dx.doi.org/10.1136/rmdopen-2017-000446

Ejemplares similares